AOP Health Starts Research for Leukemia Treatment | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.
AOP Health signed an agreement with Leukos Biotech for the further development of a newly discovered chemical substance. With this agreement AOP Health.
August 1, 2022 – Indonesia Tribune indonesiatribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indonesiatribune.com Daily Mail and Mail on Sunday newspapers.
AOP Orphan: PAH Treatment for Patients in Argentina
AOP Orphan: PAH Treatment for Patients in Argentina
Wien (pts030/26.01.2021/14:35) -
The Austrian pharmaceutical company AOP Orphan joined forces with the Argentinean company Tuteur to bring treatment to patients in Argentina suffering from Pulmonary Arterial Hypertension (PAH). The respective agreement was signed in December 2020.
AOP Orphan Pharmaceuticals AG (AOP Orphan) is a European pioneer in the field of special diseases offering treatment for PAH patients: A permanent subcutaneous application via a pump. The therapy increases life expectation and quality of life, i.e. allowing patients to walk (again) longer distances without being out of breath and following a rather normal every-day life. To achieve this improved quality of life, it is not only the drug that is needed, but a lot of knowledge and experience with the general therapy approach. Business partners like Tuteur use this know-how as part of the package. This